BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32840470)

  • 41. Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment.
    Nakajima T; Yasufuku K; Nakajima M; Baba M; Yoshikawa K; Kamada T; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
    J Thorac Oncol; 2010 May; 5(5):606-11. PubMed ID: 20354458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Percutaneous CT-guided biopsy of lytic bone lesions in patients clinically suspected of lung cancer: Diagnostic performances for pathological diagnosis and molecular testing.
    Toffart AC; Asfari S; Mc Leer A; Reymond E; Jankowski A; Moro-Sibilot D; Stephanov O; Ghelfi J; Lantuejoul S; Ferretti GR
    Lung Cancer; 2020 Feb; 140():93-98. PubMed ID: 31901769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CT scan prior to radiotherapy in unresectable, locally advanced, non-small cell carcinoma of the lung: is it always necessary?
    Calvo Temprano D; Esteban E; Jiménez Fonseca P; Fernández-Mariño B
    Clin Transl Oncol; 2017 Jan; 19(1):105-110. PubMed ID: 27091132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is a selective brain (18)F-FDG PET/CT study profitable in patients with small cell lung cancer?
    Palomar Muñoz A; García Vicente AM; Bellón Guardia ME; González García B; Talavera Rubio MP; Pilkington Woll JP; Núñez García A; Poblete García VM; Cordero García JM; Soriano Castrejón A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):124-9. PubMed ID: 21722995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is routine baseline brain imaging needed for all newly diagnosed non-small-cell lung cancer patients?
    Abdel-Rahman O
    J Comp Eff Res; 2019 Jun; 8(8):569-575. PubMed ID: 31116030
    [No Abstract]   [Full Text] [Related]  

  • 46. Adverse Prognostic CT Findings for Patients With Advanced Lung Adenocarcinoma Receiving First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy.
    Chang S; Hur J; Hong YJ; Lee HJ; Kim YJ; Han K; Choi BW
    AJR Am J Roentgenol; 2018 Jan; 210(1):43-51. PubMed ID: 29091002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of early tumor reduction on outcome differs by histological subtype in stage III non-small-cell lung cancer treated with definitive radiotherapy.
    Kanzaki H; Kataoka M; Nishikawa A; Uwatsu K; Nagasaki K; Nishijima N; Ochi T; Mochizuki T
    Int J Clin Oncol; 2016 Oct; 21(5):853-861. PubMed ID: 27125214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma.
    Lee HY; Lee KS; Kim BT; Cho YS; Lee EJ; Yi CA; Chung MJ; Kim TS; Kwon OJ; Kim H
    J Korean Med Sci; 2009 Dec; 24(6):1132-8. PubMed ID: 19949671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.
    Katoh N; Soda I; Tamamura H; Takahashi S; Uchinami Y; Ishiyama H; Ota K; Inoue T; Onimaru R; Shibuya K; Hayakawa K; Shirato H
    Radiat Oncol; 2017 Jan; 12(1):3. PubMed ID: 28057036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic impact of integrated 18F-FDG PET/MRI in cerebral staging of patients with non-small cell lung cancer.
    Deuschl C; Nensa F; Grueneisen J; Poeppel TD; Sawicki LM; Heusch P; Gramsch C; Mönninghoff C; Quick HH; Forsting M; Umutlu L; Schlamann M
    Acta Radiol; 2017 Aug; 58(8):991-996. PubMed ID: 28273734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: a regional teaching hospital experience.
    Geraldson CT; Stephenson JE; Lagrew JP; Schammel CM; Schammel DP; Greene RA; Bolton WD
    Am Surg; 2012 Mar; 78(3):305-8. PubMed ID: 22524768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
    Hricak H; Gatsonis C; Chi DS; Amendola MA; Brandt K; Schwartz LH; Koelliker S; Siegelman ES; Brown JJ; McGhee RB; Iyer R; Vitellas KM; Snyder B; Long HJ; Fiorica JV; Mitchell DG; ;
    J Clin Oncol; 2005 Dec; 23(36):9329-37. PubMed ID: 16361632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Advanced Pneumonic-type Lung Carcinoma: A Retrospective Study of Clinical-radiological-pathological Characteristics with Survival Analysis in A Single Chinese Hospital].
    Liu Y; Li J; Wang S; Chen M; Zhao J; Jiang D; Zhong W; Xu Y; Wang M
    Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):329-335. PubMed ID: 31196365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overuse of Diagnostic Brain Imaging Among Patients With Stage IA Non-Small Cell Lung Cancer.
    Milligan MG; Cronin AM; Colson Y; Kehl K; Yeboa DN; Schrag D; Chen AB
    J Natl Compr Canc Netw; 2020 May; 18(5):547-554. PubMed ID: 32380461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics.
    Kishi K; Homma S; Kurosaki A; Motoi N; Kohno T; Nakata K; Yoshimura K
    Lung Cancer; 2004 Apr; 44(1):43-51. PubMed ID: 15013582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer.
    Shin J; Keam B; Kim M; Park YS; Kim TM; Kim DW; Kim YW; Heo DS
    J Thorac Oncol; 2017 Mar; 12(3):520-528. PubMed ID: 27867003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.
    Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):574-9. PubMed ID: 22689182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor Volume Is Better Than Diameter for Predicting the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
    Xie HJ; Zhang X; Mo YX; Long H; Rong TH; Su XD
    Ann Surg Oncol; 2019 Aug; 26(8):2401-2408. PubMed ID: 31054041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.